Myomo, Inc.
Myomo, Inc. (MYO) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Myomo, Inc. (MYO), covering cash flow, earnings, and balance sheets.
Myomo, Inc. (MYO) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Myomo, Inc. MYO financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $9.83M | $12.07M | $9.21M | $7.52M |
| Cost of Revenue | $3.22M | $3.45M | $2.26M | $2.20M |
| Gross Profit | $6.61M | $8.62M | $6.95M | $5.33M |
| Gross Profit Ratio | $0.67 | $0.71 | $0.75 | $0.71 |
| R&D Expenses | $1.79M | $1.56M | $1.25M | $1.007M |
| SG&A Expenses | $8.34M | $7.30M | $6.65M | $5.43M |
| Operating Expenses | $10.13M | $8.86M | $7.90M | $6.44M |
| Total Costs & Expenses | $13.35M | $12.31M | $10.17M | $8.64M |
| Interest Income | $0.00 | $70031.00 | $76020.00 | $107242.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $466034.00 | $0.00 | $101377.00 |
| EBITDA | -$3.52M | $290751.00 | -$957553.00 | -$1.01M |
| EBITDA Ratio | -$0.36 | $0.02 | -$0.10 | -$0.13 |
| Operating Income | -$3.52M | -$245314.00 | -$957553.00 | -$1.12M |
| Operating Income Ratio | -$0.36 | -$0.02 | -$0.10 | -$0.15 |
| Other Income/Expenses (Net) | $191991.00 | $70031.00 | $76020.00 | $107242.00 |
| Income Before Tax | -$3.33M | -$175283.00 | -$881533.00 | -$1.008M |
| Income Before Tax Ratio | -$0.34 | -$0.01 | -$0.10 | -$0.13 |
| Income Tax Expense | $136795.00 | $84798.00 | $84876.00 | $113785.00 |
| Net Income | -$3.47M | -$260081.00 | -$966409.00 | -$1.12M |
| Net Income Ratio | -$0.35 | -$0.02 | -$0.10 | -$0.15 |
| EPS | -$0.08 | -$0.007 | -$0.03 | -$0.03 |
| Diluted EPS | -$0.08 | -$0.007 | -$0.03 | -$0.03 |
| Weighted Avg Shares Outstanding | $41.45M | $38.91M | $37.95M | $37.37M |
| Weighted Avg Shares Outstanding (Diluted) | $41.45M | $38.91M | $37.95M | $37.37M |
Over the past four quarters, Myomo, Inc. demonstrated steady revenue growth, increasing from $7.52M in Q2 2024 to $9.83M in Q1 2025. Operating income reached -$3.52M in Q1 2025, maintaining a consistent -36% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$3.52M, reflecting operational efficiency. Net income dropped to -$3.47M, with EPS at -$0.08. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan